Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma

被引:1
|
作者
Dehbidi, Sahar [1 ]
Farokhizadeh, Zhaleh [1 ]
Karimi, Mohammad Hossein [2 ]
Afshari, Afsoon [2 ]
Behmanesh, Mehrdad [3 ]
Sanati, Mohammad Hossein [4 ]
Geramizadeh, Bita [2 ]
Yaghobi, Ramin [2 ]
机构
[1] Nour Danesh Inst Higher Educ, Fac Biol Sci, Dept Biol, Esfahan, Iran
[2] Shiraz Univ Med Sci, Shiraz Transplant Res Ctr, Shiraz, Iran
[3] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran
[4] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran
关键词
Hepatocellular Carcinoma; MicroRNA; Liver Transplantation; Rejection; Polymorphism; TURKISH POPULATION; FUNCTIONAL POLYMORPHISM; EXPRESSION PATTERNS; HUMAN CANCER; ASSOCIATION; RISK; INFECTION; SUSCEPTIBILITY; MIR-499A-GREATER-THAN-G; CONTRIBUTES;
D O I
10.5812/hepatmon.102690
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Genetic polymorphism in the miRNA sequence might alter miRNA expression and/or maturation, which is associated with the development and progression of hepatocellular carcinoma (HCC) in liver transplant patients. Objectives: Therefore, the prevalence of miRNA-146a G > C (rs2910164), miRNA-499A > G (rs3746444), miRNA-149C > T (rs2292832), and miRNA-196a-2 C > T (rs11614913) gene polymorphisms was evaluated in liver recipients with HCC with or without experiencing graft rejection. Methods: In a cross-sectional study, tissue samples were collected from 60 HCC patients who underwent liver transplant surgery at Namazi Hospital, Shiraz, Iran, in 2013 - 2015. A control group consisting of 120 individuals was randomly selected, as well. The genomic DNA was extracted from collected tissues and blood samples. The miRNA-146a (rs2910164), miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) gene polymorphisms were evaluated in patients with HCC using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: The CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism were significantly associated with the increased risk of transplant rejection in patients with HCC (P = 0.05 and P = 0.05, respectively). The CC genotype and C allele of the miRNA-146a (rs2910164) were also significantly more frequent in male liver transplant patients who experienced acute rejection than in non-rejected ones (P = 0.05 and P = 0.03, respectively). However, no significant association was found between the genotypes and alleles of miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) polymorphisms and HCC outcomes in liver transplant recipients. Conclusions: The importance of the CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism in increasing the risk of transplant rejection was confirmed, but it needs further studies in larger populations.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
    Washburn, K.
    Edwards, E.
    Harper, A.
    Freeman, R. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (07) : 1643 - 1648
  • [32] Role of hepatocellular carcinoma therapy for patients in the waiting list for liver transplant
    Pascual, S.
    Irurzun, J.
    Miralles, C.
    Bernabe, J. M.
    Rodriguez, M.
    Bellot, P.
    Melgar, P.
    Alcazar, C.
    Lluis, F.
    Palazon, J. M.
    Rodriguz-Laiz, G.
    TRANSPLANTATION, 2021, 105 (08) : 130 - 130
  • [33] Treating Hepatocellular Carcinoma With Sorafenib in Liver Transplant Patients: An Initial Experience
    Saidi, R. F.
    Shah, S. A.
    Rawson, A. P.
    Grossman, St
    Piperdi, B.
    Bozorgzadeh, A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4582 - 4584
  • [34] Hepatocellular carcinoma in advanced liver cirrhosis: CT detection in transplant patients
    Lim, JH
    Park, CK
    ABDOMINAL IMAGING, 2004, 29 (02): : 203 - 207
  • [35] Sex and Size Disparities in Access to Liver Transplant for Patients With Hepatocellular Carcinoma
    Cron, David C.
    Mazur, Rafal D.
    Bhan, Irun
    Adler, Joel T.
    Yeh, Heidi
    JAMA SURGERY, 2024, 159 (11) : 1291 - 1298
  • [36] Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma
    Park, Sang-Jae
    Freise, Chris E.
    Hirose, Ryutaro
    Kerlan, Robert K.
    Yao, Francis Y.
    Roberts, John P.
    Vagefi, Parsia A.
    CLINICAL TRANSPLANTATION, 2012, 26 (04) : E359 - E364
  • [37] An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?
    Chui, AKK
    Rao, ARN
    McCaughan, GW
    Waugh, R
    Verran, DJ
    Koorey, D
    Painter, D
    Sheil, AGR
    CLINICAL TRANSPLANTATION, 1999, 13 (06) : 531 - 535
  • [38] Survival benefit of living donor liver transplant for patients with hepatocellular carcinoma
    Kaslow, Sarah R.
    Torres-Hernandez, Alejandro
    Su, Feng
    Liapakis, Annmarie
    Griesemer, Adam
    Halazun, Karim J.
    UPDATES IN SURGERY, 2024,
  • [39] Hepatocellular carcinoma in advanced liver cirrhosis: CT detection in transplant patients
    J. H. Lim
    C. K. Park
    Abdominal Imaging, 2004, 29 : 203 - 207
  • [40] Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population
    Kim, Won Hee
    Min, Kyung Tae
    Jeon, Young Joo
    Kwon, Chang-Il
    Ko, Kwang Hyun
    Park, Pil Won
    Hong, Sung Pyo
    Rim, Kyu Seong
    Kwon, Sung Won
    Hwang, Seong Gyu
    Kim, Nam Keun
    GENE, 2012, 504 (01) : 92 - 97